Identification of the FBXO22/LKB1/AMPK/ mTOR axis in this study not only provides great insight into how LKB1 kinase activity is regulated, but also highlights FBXO22 as a potential target for lung cancer therapy. Here, PRKAA1 is linked to lung cancer.